Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking) Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations)-Global Forecast to 2025
“The rising R&D expenditure, growing support for research, stringent regulatory guidelines especially in the area of rare diseases, and the rising use of informatics in drug discovery are expected to drive the overall growth of the drug discovery informatics market.”
The global drug discovery informatics market is projected to reach USD 3.5 billion in 2025 from USD 2.2 billion in 2020, at a CAGR of 9.3% during the forecast period. Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the rising use of informatics in drug discovery. However, the scarcity of skilled professionals and the high setup cost of informatics software is expected to limit market growth to a certain extent.
“The sequence and target data analysis segment commanded the largest share of the market in 2019.”
On the basis of function the market is broadly segmented into sequencing and target data analysis, docking, molecular modeling, library & database preparation, and other functions. The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.
“The software market dominated the market, by solution segment, in 2019”
Based on solution the drug discovery informatics market is segmented into software and services. The large share of this segment is primarily attributed to the rising demand for new chemical entities due to the rise in new disease prevalence. Software helps eliminate the chance of drug failure, on a broad scope, and fulfills a wide range of other functionalities. This has ensured the demand for drug discovery informatics software among end-users.
“The pharmaceutical companies segment commanded the largest share of the drug discovery informatics market in 2019.”
By the end-user, the drug discovery informatics market is segmented into pharmaceutical companies, biotechnology companies, contract research organizations (CROs) and other end users. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019, pharmaceutical companies are using this informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment.
“The Asia Pacific region to register the highest growth in the global drug discovery informatics market during the forecast period.”
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the MIS instruments market.
The study includes an in-depth competitive analysis of these key players in the drug discovery informatics market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the drug discovery informatics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on product, type of surgery, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall drug discovery informatics market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights so as to better position their businesses, and to plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.
The global drug discovery informatics market is projected to reach USD 3.5 billion in 2025 from USD 2.2 billion in 2020, at a CAGR of 9.3% during the forecast period. Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the rising use of informatics in drug discovery. However, the scarcity of skilled professionals and the high setup cost of informatics software is expected to limit market growth to a certain extent.
“The sequence and target data analysis segment commanded the largest share of the market in 2019.”
On the basis of function the market is broadly segmented into sequencing and target data analysis, docking, molecular modeling, library & database preparation, and other functions. The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.
“The software market dominated the market, by solution segment, in 2019”
Based on solution the drug discovery informatics market is segmented into software and services. The large share of this segment is primarily attributed to the rising demand for new chemical entities due to the rise in new disease prevalence. Software helps eliminate the chance of drug failure, on a broad scope, and fulfills a wide range of other functionalities. This has ensured the demand for drug discovery informatics software among end-users.
“The pharmaceutical companies segment commanded the largest share of the drug discovery informatics market in 2019.”
By the end-user, the drug discovery informatics market is segmented into pharmaceutical companies, biotechnology companies, contract research organizations (CROs) and other end users. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019, pharmaceutical companies are using this informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment.
“The Asia Pacific region to register the highest growth in the global drug discovery informatics market during the forecast period.”
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the MIS instruments market.
- By Respondent Type: Supply Side (80%) and Demand Side (20%)
- By Designation: Managers (55%), CXOs (20%), and Executives (25%)
- By Region: North America (50%), Europe (20%), APAC (20%), and RoW (10%)
The study includes an in-depth competitive analysis of these key players in the drug discovery informatics market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the drug discovery informatics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on product, type of surgery, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall drug discovery informatics market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights so as to better position their businesses, and to plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.4 DATA TRIANGULATION
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DRUG DISCOVERY INFORMATICS MARKET OVERVIEW
4.2 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION AND COUNTRY (2019)
4.3 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION (USD MILLION)
4.4 DRUG DISCOVERY INFORMATICS MARKET SHARE, BY END USER, 2019
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increased research spending on informatics by the pharmaceutical and biotechnology industries
5.2.1.2 Growing demand and support for rare disease and orphan drug research
5.2.1.3 Focus on drug discovery using informatics software
5.2.2 RESTRAINTS
5.2.2.1 High setup costs of informatics software
5.2.3 OPPORTUNITIES
5.2.3.1 Patent expiry
5.2.3.2 Growing biotechnology industry and biologics market
5.2.3.3 Growth in emerging markets
5.2.4 CHALLENGE
5.2.4.1 Dearth of skilled professionals
6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
6.1 INTRODUCTION
6.2 SEQUENCING & TARGET DATA ANALYSIS
6.2.1 SEQUENCING & TARGET DATA ANALYSIS HOLDS LARGEST SHARE OF THE MARKET, BY FUNCTION
6.3 DOCKING
6.3.1 MOLECULAR DOCKING TARGETS THE DEVELOPMENT OF POTENTIAL MOLECULES
6.4 MOLECULAR MODELING
6.4.1 CAPABILITY TO GENERATE ESTIMATIONS OF DRUG POTENTIAL MAKE MODELING A PROMINENT TOOL
6.5 LIBRARY & DATABASE PREPARATION
6.5.1 INCREASE IN DRUG RESEARCH IS EXPANDING THE USE OF DRUG DATABASES
6.6 OTHER FUNCTIONS
7 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 DRUG DEVELOPMENT
7.2.1 PRECLINICAL TESTING
7.2.1.1 Growth in the number of preclinical testing activities to support market growth
7.2.2 CLINICAL TRIALS
7.2.2.1 Informatics software help assess important aspects about clinical trial success
7.3 DRUG DISCOVERY
7.3.1 INCREASED SPENDING ON DRUG DISCOVERY TO DRIVE MARKET GROWTH
8 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION
8.1 INTRODUCTION
8.2 SOFTWARE
8.2.1 BENEFITS OF INFORMATICS SOFTWARE IN DRUG DISCOVERY ARE DRIVING THE GROWTH OF THE MARKET
8.3 SERVICES
8.3.1 A WIDE RANGE OF SERVICES IS AVAILABLE IN THE MARKET, FROM INSTALLATION TO POST-SALES SUPPORT
9 DRUG DISCOVERY INFORMATICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL COMPANIES
9.2.1 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 INCREASING DEMAND FOR PERSONALIZED MEDICINE TO BOOST THE USE OF INFORMATICS IN BIOTECHNOLOGY COMPANIES
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 RISE IN OUTSOURCING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
9.5 OTHER END USERS
10 DRUG DISCOVERY INFORMATICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising R&D to support the growth of the drug discovery informatics market in the US
10.2.2 CANADA
10.2.2.1 Presence of a strong pharmaceuticals industry to propel market growth in Canada
10.3 EUROPE
10.3.1 UK
10.3.1.1 The UK is the largest market for drug discovery informatics in Europe
10.3.2 FRANCE
10.3.2.1 Loss of patent exclusivity of biologics to support the growth of the drug discovery informatics market in France
10.3.3 GERMANY
10.3.3.1 Increasing focus on drug discovery & development to drive market growth
10.3.4 ITALY
10.3.4.1 High production volume to boost drug informatics growth
10.3.5 SPAIN
10.3.5.1 Rising R&D expenditure to drive market growth in Spain
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Large R&D pharmaceutical footprint to drive market growth in China
10.4.2 INDIA
10.4.2.1 Presence of a large number of CROs in India to propel market growth
10.4.3 JAPAN
10.4.3.1 Rising government initiatives for drug discovery to support the adoption of informatics software in Japan
10.4.4 REST OF ASIA PACIFIC
10.5 ROW
10.5.1 LATIN AMERICA IS AN ATTRACTIVE MARKET FOR DRUG DISCOVERY INFORMATICS IN THE ROW
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS, 2018
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 DYNAMIC DIFFERENTIATORS
11.3.3 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 KEY PRODUCT & SERVICE LAUNCHES
11.4.2 KEY ACQUISITIONS
11.4.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
11.4.4 KEY EXPANSIONS
12 COMPANY PROFILES
12.1 JUBILANT LIFE SCIENCES
12.2 CHARLES RIVER LABORATORIES INTERNATIONAL
12.3 IBM
12.4 CLARIVATE ANALYTICS
12.5 ACCENTURE
12.6 PERKINELMER
12.7 DASSAULT SYST?MES
12.8 EUROFINS SCIENTIFIC
12.9 EVOTEC AG
12.10 COGNIZANT
12.11 INFOSYS LIMITED
12.12 THERMO FISHER SCIENTIFIC
12.13 ALBANY MOLECULAR RESEARCH
12.14 SCHR?DINGER
12.15 SELVITA
12.16 CERTARA
12.17 GVK BIOSCIENCES
12.18 OPENEYE SCIENTIFIC SOFTWARE
12.19 IO INFORMATICS
12.20 CDD
*Details on Business Overview, Products/Servies Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.4 DATA TRIANGULATION
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DRUG DISCOVERY INFORMATICS MARKET OVERVIEW
4.2 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION AND COUNTRY (2019)
4.3 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION (USD MILLION)
4.4 DRUG DISCOVERY INFORMATICS MARKET SHARE, BY END USER, 2019
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increased research spending on informatics by the pharmaceutical and biotechnology industries
5.2.1.2 Growing demand and support for rare disease and orphan drug research
5.2.1.3 Focus on drug discovery using informatics software
5.2.2 RESTRAINTS
5.2.2.1 High setup costs of informatics software
5.2.3 OPPORTUNITIES
5.2.3.1 Patent expiry
5.2.3.2 Growing biotechnology industry and biologics market
5.2.3.3 Growth in emerging markets
5.2.4 CHALLENGE
5.2.4.1 Dearth of skilled professionals
6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
6.1 INTRODUCTION
6.2 SEQUENCING & TARGET DATA ANALYSIS
6.2.1 SEQUENCING & TARGET DATA ANALYSIS HOLDS LARGEST SHARE OF THE MARKET, BY FUNCTION
6.3 DOCKING
6.3.1 MOLECULAR DOCKING TARGETS THE DEVELOPMENT OF POTENTIAL MOLECULES
6.4 MOLECULAR MODELING
6.4.1 CAPABILITY TO GENERATE ESTIMATIONS OF DRUG POTENTIAL MAKE MODELING A PROMINENT TOOL
6.5 LIBRARY & DATABASE PREPARATION
6.5.1 INCREASE IN DRUG RESEARCH IS EXPANDING THE USE OF DRUG DATABASES
6.6 OTHER FUNCTIONS
7 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 DRUG DEVELOPMENT
7.2.1 PRECLINICAL TESTING
7.2.1.1 Growth in the number of preclinical testing activities to support market growth
7.2.2 CLINICAL TRIALS
7.2.2.1 Informatics software help assess important aspects about clinical trial success
7.3 DRUG DISCOVERY
7.3.1 INCREASED SPENDING ON DRUG DISCOVERY TO DRIVE MARKET GROWTH
8 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION
8.1 INTRODUCTION
8.2 SOFTWARE
8.2.1 BENEFITS OF INFORMATICS SOFTWARE IN DRUG DISCOVERY ARE DRIVING THE GROWTH OF THE MARKET
8.3 SERVICES
8.3.1 A WIDE RANGE OF SERVICES IS AVAILABLE IN THE MARKET, FROM INSTALLATION TO POST-SALES SUPPORT
9 DRUG DISCOVERY INFORMATICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL COMPANIES
9.2.1 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 INCREASING DEMAND FOR PERSONALIZED MEDICINE TO BOOST THE USE OF INFORMATICS IN BIOTECHNOLOGY COMPANIES
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 RISE IN OUTSOURCING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
9.5 OTHER END USERS
10 DRUG DISCOVERY INFORMATICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising R&D to support the growth of the drug discovery informatics market in the US
10.2.2 CANADA
10.2.2.1 Presence of a strong pharmaceuticals industry to propel market growth in Canada
10.3 EUROPE
10.3.1 UK
10.3.1.1 The UK is the largest market for drug discovery informatics in Europe
10.3.2 FRANCE
10.3.2.1 Loss of patent exclusivity of biologics to support the growth of the drug discovery informatics market in France
10.3.3 GERMANY
10.3.3.1 Increasing focus on drug discovery & development to drive market growth
10.3.4 ITALY
10.3.4.1 High production volume to boost drug informatics growth
10.3.5 SPAIN
10.3.5.1 Rising R&D expenditure to drive market growth in Spain
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Large R&D pharmaceutical footprint to drive market growth in China
10.4.2 INDIA
10.4.2.1 Presence of a large number of CROs in India to propel market growth
10.4.3 JAPAN
10.4.3.1 Rising government initiatives for drug discovery to support the adoption of informatics software in Japan
10.4.4 REST OF ASIA PACIFIC
10.5 ROW
10.5.1 LATIN AMERICA IS AN ATTRACTIVE MARKET FOR DRUG DISCOVERY INFORMATICS IN THE ROW
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS, 2018
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 DYNAMIC DIFFERENTIATORS
11.3.3 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 KEY PRODUCT & SERVICE LAUNCHES
11.4.2 KEY ACQUISITIONS
11.4.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
11.4.4 KEY EXPANSIONS
12 COMPANY PROFILES
12.1 JUBILANT LIFE SCIENCES
12.2 CHARLES RIVER LABORATORIES INTERNATIONAL
12.3 IBM
12.4 CLARIVATE ANALYTICS
12.5 ACCENTURE
12.6 PERKINELMER
12.7 DASSAULT SYST?MES
12.8 EUROFINS SCIENTIFIC
12.9 EVOTEC AG
12.10 COGNIZANT
12.11 INFOSYS LIMITED
12.12 THERMO FISHER SCIENTIFIC
12.13 ALBANY MOLECULAR RESEARCH
12.14 SCHR?DINGER
12.15 SELVITA
12.16 CERTARA
12.17 GVK BIOSCIENCES
12.18 OPENEYE SCIENTIFIC SOFTWARE
12.19 IO INFORMATICS
12.20 CDD
*Details on Business Overview, Products/Servies Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 2 DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2017–2025 (USD MILLION)
TABLE 3 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 4 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 5 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 6 DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2017–2025 (USD MILLION)
TABLE 7 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 8 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 9 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 10 DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY REGION, 2017–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 12 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 13 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 14 DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY REGION, 2017–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 16 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 17 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 18 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 19 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 20 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 21 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 22 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 23 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 25 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 26 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 27 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 28 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 29 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 30 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 31 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 32 DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY REGION, 2017–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 34 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 35 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 36 DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION, 2017–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 38 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 39 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 40 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 41 DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2017–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 43 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 44 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 45 DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 47 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 49 DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 50 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 51 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 52 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 53 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 55 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017–2025 (USD MILLION)
TABLE 56 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 57 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2017–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 63 US: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 64 US: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 65 US: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 66 US: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 67 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 68 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 69 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 70 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 71 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 72 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 73 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 74 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 75 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 76 UK: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 77 UK: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 78 UK: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 79 UK: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 80 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 81 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 82 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 83 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 84 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 85 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 86 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 87 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 88 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 89 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 90 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 91 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 92 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 93 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 94 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 95 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 96 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 97 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 98 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 99 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 100 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 101 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 102 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 103 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 104 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 105 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 106 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 107 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 108 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 109 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 110 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 111 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 112 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 113 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 114 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 115 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 116 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 117 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 118 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 119 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 120 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 121 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 122 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 123 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 124 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 1 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 2 DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2017–2025 (USD MILLION)
TABLE 3 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 4 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 5 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 6 DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2017–2025 (USD MILLION)
TABLE 7 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 8 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 9 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 10 DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY REGION, 2017–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 12 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 13 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 14 DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY REGION, 2017–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 16 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 17 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 18 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 19 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 20 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 21 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 22 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 23 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 25 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 26 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 27 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 28 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 29 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 30 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 31 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 32 DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY REGION, 2017–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 34 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 35 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 36 DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION, 2017–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 38 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 39 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 40 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 41 DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2017–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 43 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 44 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 45 DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 47 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 49 DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2025 (USD MILLION)
TABLE 50 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 51 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 52 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 53 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 55 EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017–2025 (USD MILLION)
TABLE 56 APAC: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 57 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2017–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 63 US: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 64 US: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 65 US: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 66 US: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 67 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 68 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 69 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 70 CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 71 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 72 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 73 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 74 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 75 EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 76 UK: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 77 UK: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 78 UK: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 79 UK: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 80 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 81 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 82 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 83 FRANCE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 84 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 85 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 86 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 87 GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 88 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 89 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 90 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 91 ITALY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 92 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 93 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 94 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 95 SPAIN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 96 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 97 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 98 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 99 ROE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 100 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 101 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 102 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 103 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 104 APAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 105 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 106 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 107 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 108 CHINA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 109 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 110 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 111 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 112 INDIA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 113 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 114 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 115 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 116 JAPAN: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 117 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 118 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 119 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 120 ROAPAC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
TABLE 121 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017–2025 (USD MILLION)
TABLE 122 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017–2025 (USD MILLION)
TABLE 123 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 124 ROW: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017–2025 (USD MILLION)
LIST OF FIGURES
FIGURE 1 BREAKDOWN OF PRIMARIES: DRUG DISCOVERY INFORMATICS MARKET
FIGURE 2 DATA TRIANGULATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (BOTTOM-UP APPROACH)
FIGURE 4 DRUG DISCOVERY INFORMATICS: MARKET SIZE (USD BILLION)
FIGURE 5 DRUG DISCOVERY INFORMATICS MARKET: CAGR PROJECTIONS
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, & CHALLENGES
FIGURE 7 DRUG DISCOVERY INFORMATICS MARKET SHARE & CAGR, BY FUNCTION
FIGURE 8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2019?2025
FIGURE 9 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2019 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET
FIGURE 11 RISING R&D EXPENDITURE IS THE PRIMARY GROWTH DRIVER FOR THE MARKET
FIGURE 12 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
NORTH AMERICAN DRUG DISCOVERY INFORMATICS MARKET IN 2019
FIGURE 13 SEQUENCING & TARGET DATA ANALYSIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 14 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
FIGURE 15 DRUG DISCOVERY INFORMATICS MARKET : MARKET DYNAMICS
FIGURE 16 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2019 VS. 2024
FIGURE 17 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
FIGURE 18 APAC: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
FIGURE 19 RANK OF COMPANIES IN THE DRUG DISCOVERY INFORMATICS MARKET, 2018
FIGURE 20 DRUG DISCOVERY INFORMATICS MARKET (GLOBAL) COMPETITIVE
LEADERSHIP MAPPING, 2018
FIGURE 21 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2019)
FIGURE 22 CHARLES RIVER: COMPANY SNAPSHOT (2018)
FIGURE 23 IBM: COMPANY SNAPSHOT (2018)
FIGURE 24 CLARIVATE ANALYTICS: COMPANY SNAPSHOT (2019)
FIGURE 25 ACCENTURE PLC: COMPANY SNAPSHOT : 2019
FIGURE 26 PERKINELMER: COMPANY SNAPSHOT (2018)
FIGURE 27 DASSAULT SYST?MES: COMPANY SNAPSHOT (2018)
FIGURE 28 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 29 EVOTEC: COMPANY SNAPSHOT (2018)
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2019)
FIGURE 31 INFOSYS LIMITED: COMPANY SNAPSHOT (2019)
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT: 2018
FIGURE 1 BREAKDOWN OF PRIMARIES: DRUG DISCOVERY INFORMATICS MARKET
FIGURE 2 DATA TRIANGULATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (BOTTOM-UP APPROACH)
FIGURE 4 DRUG DISCOVERY INFORMATICS: MARKET SIZE (USD BILLION)
FIGURE 5 DRUG DISCOVERY INFORMATICS MARKET: CAGR PROJECTIONS
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, & CHALLENGES
FIGURE 7 DRUG DISCOVERY INFORMATICS MARKET SHARE & CAGR, BY FUNCTION
FIGURE 8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2019?2025
FIGURE 9 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2019 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET
FIGURE 11 RISING R&D EXPENDITURE IS THE PRIMARY GROWTH DRIVER FOR THE MARKET
FIGURE 12 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
NORTH AMERICAN DRUG DISCOVERY INFORMATICS MARKET IN 2019
FIGURE 13 SEQUENCING & TARGET DATA ANALYSIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 14 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
FIGURE 15 DRUG DISCOVERY INFORMATICS MARKET : MARKET DYNAMICS
FIGURE 16 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2019 VS. 2024
FIGURE 17 NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
FIGURE 18 APAC: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
FIGURE 19 RANK OF COMPANIES IN THE DRUG DISCOVERY INFORMATICS MARKET, 2018
FIGURE 20 DRUG DISCOVERY INFORMATICS MARKET (GLOBAL) COMPETITIVE
LEADERSHIP MAPPING, 2018
FIGURE 21 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2019)
FIGURE 22 CHARLES RIVER: COMPANY SNAPSHOT (2018)
FIGURE 23 IBM: COMPANY SNAPSHOT (2018)
FIGURE 24 CLARIVATE ANALYTICS: COMPANY SNAPSHOT (2019)
FIGURE 25 ACCENTURE PLC: COMPANY SNAPSHOT : 2019
FIGURE 26 PERKINELMER: COMPANY SNAPSHOT (2018)
FIGURE 27 DASSAULT SYST?MES: COMPANY SNAPSHOT (2018)
FIGURE 28 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 29 EVOTEC: COMPANY SNAPSHOT (2018)
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2019)
FIGURE 31 INFOSYS LIMITED: COMPANY SNAPSHOT (2019)
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT: 2018
